epithalon peptide telomerase Capsules Epitalon - Wikipedia

Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase

Mallick R, Basak S, Duttaroy AK (2019) Docosahexaenoic acid,22:6n3: Its roles in the structure and function of the brain

Boroughs LK, DeBerardinis RJ

Why it was included in the FDA ban While animal studies suggest that DIHEXA may tout these brain benefits (17), the FDA says it has not identified any human exposure data. Meaning: The safety and efficacy of DIHEXA for humans is still up in the air